Larson Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Larson Financial Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,825	Closed	-$14K	–	1615
2022 Q4	$14K	Hold	15,825	–	–	﹤0.01%	773
2022 Q3	$25K	Buy	15,825 +5,000	+46%	+$11.3K	﹤0.01%	582
2022 Q2	$22K	Hold	10,825	–	–	﹤0.01%	532
2022 Q1	$25K	Buy	10,825 +6,040	+126%	+$18.8K	﹤0.01%	494
2021 Q4	$22K	Hold	4,785	–	–	﹤0.01%	524
2021 Q3	$37K	Buy	4,785 +898	+23%	+$7.62K	0.01%	353
2021 Q2	$38K	Buy	+3,887	New	+$31K	0.01%	323

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return